Preclinical Rationale for TGF-β Inhibition as a Therapeutic Target for the Treatment of Myelofibrosis

Experimental Hematology - Netherlands
doi 10.1016/j.exphem.2016.08.007
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Coagulopathy as a Therapeutic Target for TRALI: Rationale and Possible Sites of Action

Current Pharmaceutical Design
Drug DiscoveryPharmacology
2012English

Preclinical Evidence of Ghrelin as a Therapeutic Target in Epilepsy

Oncotarget
Oncology
2017English

Inhibition of L-Type Amino Acid Transporter 1 Activity as a New Therapeutic Target for Cholangiocarcinoma Treatment

Tumor Biology
MedicineCancer Research
2017English

Endocannabinoid System as Novel Therapeutic Target for Autism Treatment

Autism-Open Access
2014English

LncRNA as a Therapeutic Target for Angiogenesis

Current Topics in Medicinal Chemistry
MedicineDrug Discovery
2017English

Β-Secretase: Its Biology as a Therapeutic Target in Diseases

Trends in Pharmacological Sciences
ToxicologyPharmacology
2013English

PI 3-Kinase Inhibition: A Therapeutic Target for Respiratory Disease

Biochemical Society Transactions
Biochemistry
2004English

TIMP-3 as a Therapeutic Target for Cancer

Therapeutic Advances in Medical Oncology
Oncology
2019English

Irisin: As a Therapeutic Target for Metabolic Disorders

Journal of Endocrinology and Metabolism
EndocrinologyMetabolismDiabetes
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy